Immune Modulators To the Fore in CFS

From Health Rising

B cell lymphocyte

B cell lymphocyte

The Rituximab trials, Ampligen studies, the Etanercept work by Fluge and Mella, and statements by Dr. Klimas indicate that researchers are becoming more comfortable with the idea of using powerful immune modulators to treat chronic fatigue syndrome.

Within the past year an ME/CFS immune modulator clinical trial has begun in a country – the Netherlands – best known for its CBT studies. If the trial is successful it will open up new treatment possibilities for ME/CFS.

It’s also an example of changes that appear to be slowly occurring. Somebody, after all, got enough money together to do what an appears to be a quite expensive trial on an immune modulator in the Netherlands. That’s something to think about.

Read more:

Comments are closed.